3 strategies to reduce risk of heater-cooler infections

A team of researchers have put forth interim guidance for hospitals and health systems after analyzing outbreaks of Mycobacterium chimaera linked heater-cooler devices, commonly used during cardiac surgery, in several countries on different continents.

Advertisement

For the study, published in the journal of Infection Control & Epidemiology, researchers examined outbreaks of M. chimaera and identified common characteristics. The team found infections associated with the devices to be commonly characterized by delayed diagnosis, inadequate treatment response to antimicrobial agents and poor prognosis. They also found M. chimaera inside the heater-coolers and in air samples taken near the devices, suggesting the infections are the result of airborne transmission.

M. chimaera are a species of nontuberculous mycobacterium. The bacteria are commonly found in soil and water. While typically harmless, the bacteria can cause infections in people with weakened immune systems.

“This dangerous infection has put many patients at risk all over the world,” said Rami Sommerstein, MD, of Inselspital, Bern University Hospital in Switzerland, lead author of the study.

To prevent future cases of M. chimaera infections, researchers made three recommendations.

1. Ensure contaminated heater-coolers are completely separated from the operating room.

2. Educate clinicians on the risk and dangers associated with M. chimaera contamination.

3. Screen recent heart surgery patients demonstrating prolonged, unexplained fevers for M. chimaera.

The CDC and the Food and Drug Administration have also issued separate guidance documents on the heater-cooler machines.

In the U.S., the Mayo Clinic in Rochester, Minn., is the latest hospital of many to warn heart surgery patients about their potential exposure to NTM bacteria.

More articles on infection control: 
3 more children hospitalized with suspected AFM in Washington 
Outbreak of bloodstream infections linked to syringes reaches 149 cases 
Is the CDC surpassing the WHO in the global fight against infectious disease?

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.